Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-26

Clinical Trial Update: Minocycline to Treat Branch Retinal Vein Occlusion [Phase 1, Phase 2]

View source ↗

Summary

A post-completion update on a Phase 1/2 trial assessing minocycline for retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinal Vein Occlusion | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-26